BridgeBio Pharma Inc

NASDAQ:BBIO   10:08:22 AM EDT
6.80
+0.08 (+1.19%)
Products

BridgeBio Pharma Receives FDA Fast Track Designation for Investigational Therapy for Treatment of Limb-girdle Muscular Dystrophy Type 2i

Published: 09/15/2021 11:42 GMT
BridgeBio Pharma Inc (BBIO) - Bridgebio Pharma Receives FDA Fast Track Designation for Investigational Therapy for the Treatment of Limb-girdle Muscular Dystrophy Type 2i (lgmd2i).